The goal of this clinical trial is to test the effect of granulocyte colony-stimulating factor (G-CSF, A.K.A. Filgrastim) in infertility patients undergoing in vitro fertilization (IVF) treatment. The main question it aims to answer is: Can in vitro fertilization-embryo transfer (IVF-ET) outcomes be improved by supplementing the transfer media with Granulocyte colony-stimulating factor (GCSF)? Participants will undergo their embryo transfer as per the normal clinic protocol but will be randomized to either receive the standard embryo transfer media or the GCSG-supplemented transfer media. Researchers will compare the GCSF and standard transfer media groups to see if clinical outcomes are improved (i.e., implantation rate, pregnancy, clinical pregnancy rate, live birth rate).
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Implantation Rate
Timeframe: From enrollment to the time of 6-week ultrasound.
Clinical Pregnancy Rate
Timeframe: From enrollment to the time of 6-week ultrasound.
Pregnancy Rate
Timeframe: From enrollment to the time of blood test at 10 days post-ET.
Live Birth Rate
Timeframe: From enrollment to the time of birth (up to 9-months post-ET).